Fate Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Fate Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fate Therapeutics Inc Strategy Report
- Understand Fate Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Fate Therapeutics Catalyst Calendar
Proactively evaluate Fate Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Fate Therapeutics Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Jun 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Jan 2020 | Phase I Trial Initiation | Fate Therapeutics Inc; Sarah Cannon Research Institute LLC | FATE | FT-596 | Oncology | Chronic Lymphocytic Leukemia (CLL); Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Refractory Chronic Lymphocytic Leukemia (CLL); Relapsed Chronic Lymphocytic Leukemia (CLL); Unspecified B-Cell Lymphomas | Clinical Trial Registry |
| 31 Dec 2019 | Phase I Trial Results | Fate Therapeutics Inc | FATE | FATENK-100 | Oncology | Breast Cancer; Colorectal Cancer; Gastric Cancer; Head And Neck Cancer; Head And Neck Cancer Squamous Cell Carcinoma; Hepatocellular Carcinoma; Melanoma; Non-Small Cell Lung Cancer; Pancreatic Cancer; Renal Cell Carcinoma; Small-Cell Lung Cancer; Solid Tumor | Company Presentation |
| 01 Dec 2019 | Phase II Trial Initiation | Fate Therapeutics Inc | FATE | FATENK-100 | Oncology | Blood Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer